Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02126 JW THERAP-B
RT Nominal up1.430 +0.010 (+0.704%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others285,331-18.034%348,107319,894285,224178,932
Land & other Lease Assets55,80023.692%45,11245,78422,63623,784
Intangible Assets711,215-20.418%893,684816,289774,974156,947
Interests in Asso. & JCEs0--0000
Other Non-current Assets26,26736.268%19,27639,59949,29947,616

1,078,613-17.422%1,306,1791,221,5661,132,133407,279
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories34,778-13.399%40,15931,4029550
Trade Receivables0--5,305000
Cash & Bank Balances1,005,909-27.284%1,383,3361,834,3992,630,598254,866
Other Current Assets26,797-52.461%56,36829,23915,8066,474
Assets Held for Sale0--0000

1,067,484-28.124%1,485,1681,895,0402,647,359261,340
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables3,269-57.009%7,6042,5659020
S-T Debt & Leases121,005-20.860%152,90020,18610,88110,096
Other Current Liabilities140,195-6.742%150,331176,149225,262112,721
Liab asso w/ Assets Held for Sale0--0000

264,469-14.917%310,835198,900237,045122,817
Net Current Assets803,015-31.619%1,174,3331,696,1402,410,314138,523
Total Assets Less Current Liabilities1,881,628-24.144%2,480,5122,917,7063,542,447545,802
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases197,79056.693%126,228126,849112,71267,687
Other Non-current Liabilities0--0001,420,454

197,79056.693%126,228126,849112,7121,488,141
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital270.000%2727264
  Reserves1,683,811-28.478%2,354,2572,790,8303,429,709(942,343)
  Others0--0000
Shareholders' Funds1,683,838-28.478%2,354,2842,790,8573,429,735(942,339)
Non-controlling Interests0--0000
Others0--0000

1,683,838-28.478%2,354,2842,790,8573,429,735(942,339)
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments2,553-41.243%4,34515,66520,9882,709
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 20/08/2024 11:53
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -767,996,000
%Change-9.235%
EPS / (LPS)RMB -1.870
NBV Per Share (¥)RMB 4.083
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.